2013
DOI: 10.3109/21691401.2012.762652
|View full text |Cite
|
Sign up to set email alerts
|

Hemoglobin–albumin cross-linking with disuccinimidyl suberate (DSS) and/or glutaraldehyde for blood substitutes

Abstract: Hemoglobin (Hb) derivatization for blood substitute purposes often involves multi-step processes including redox reagents such as borohydride and periodate, with possible subsequent side effects. Disuccinimidyl suberate (DSS) allows protein cross-linking without toxic side-products, forming one-step peptide bonds with the lysine residues. Here, we report that Hb polymers were obtained using DSS, making this the first report of a single-step polymerization for blood substitutes. The increase in autooxidation ra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
26
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 17 publications
(29 citation statements)
references
References 20 publications
3
26
0
Order By: Relevance
“…They allow protein crosslinking without toxic side-products and forming peptide bond with lysine residue in one single step [29]. …”
Section: Single-step Hemoglobin Derivatizationmentioning
confidence: 99%
See 1 more Smart Citation
“…They allow protein crosslinking without toxic side-products and forming peptide bond with lysine residue in one single step [29]. …”
Section: Single-step Hemoglobin Derivatizationmentioning
confidence: 99%
“…The copolymers show very little change in autooxidation and oxygen affinity compared to native Hb, and low intensity of free radicals – less than in native Hb [29]. …”
Section: Single-step Hemoglobin Derivatizationmentioning
confidence: 99%
“…However, this attachment method required a "linker arm" modification of Hb. The multiple modification steps in this method are laborious and have the potential to cause Hb instability or precipitation [14].…”
Section: Introductionmentioning
confidence: 99%
“…Designing low oxygen affinity blood substitutes with enhanced molecular size (dimensions) has been initially attempted by one-step oligomerization platform that introduces intra and intermolecular crosslinking using glutaraldehyde. Chang introduced the oligomerization concept (Chang 1964(Chang , 1971, and since then many new bifunctional crosslinkers have been advanced for the oligomerization of Hb (Bunn et al 1969;Payne 1973;Marini et al 1989;D'Agnillo and Chang 1998;Hai et al 1999;MacDonald and Pepper 1994;Hai et al 1994;Bakker et al 1992;Dellacherie and Vigneron 1991;Zhang and Palmer 2010;Faggiano et al 2010;Tarasov et al 2007;Buehler et al 2006;Scurtu et al 2013;Berbers et al 1991;Adachi et al 1991).…”
Section: Enhancing the Molecular Dimensions Of Hb By Oligomerizationmentioning
confidence: 99%